This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
04/28/16 - 3:59:53 PM ET (BATS BZX Real-time Price)
Div Yield: --
PGNX Day's Range
PGNX 52 Week Range
PGNX Business Summary
Progenics Pharmaceuticals, Inc. develops medicines for oncology in the United States and internationally.View PGNX
Progenics Pharmaceuticals Inc - PGNX - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Progenics Pharmaceuticals Inc as a
Sell with a ratings score of D.
Report Snippet: We rate PROGENICS PHARMACEUTICAL INC (PGNX) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself.